SI2324853T1 - Liksisenatid kot dodatek metforminu pri zdravljenju sladkorne bolezni tipa 2 - Google Patents

Liksisenatid kot dodatek metforminu pri zdravljenju sladkorne bolezni tipa 2

Info

Publication number: SI2324853T1
Authority: SI; Slovenia
Prior art keywords: lixisenatide; metformin; add; treatment; diabetes type
Prior art date: 2009-11-13

Application number

SI200931317T

Other languages

English (en)

Inventor

Louise Silvestre

Caroline Sert-Langeron

Tianyue Zhou

Original Assignee

Sanofi-Aventis Deutschland Gmbh

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2009-11-13

Filing date

2009-11-13

Publication date

2015-12-31

Family has litigation

First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=41728467&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=SI2324853(T1) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.

2009-11-13 Application filed by Sanofi-Aventis Deutschland Gmbh filed Critical Sanofi-Aventis Deutschland Gmbh

2015-12-31 Publication of SI2324853T1 publication Critical patent/SI2324853T1/sl

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A61K31/155—Amidines (), e.g. guanidine (H2N—C(=NH)—NH2), isourea (N=C(OH)—NH2), isothiourea (—N=C(SH)—NH2)
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/22—Hormones
- A61K38/26—Glucagons
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Pharmacology & Pharmacy (AREA)
Epidemiology (AREA)
Animal Behavior & Ethology (AREA)
General Health & Medical Sciences (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Endocrinology (AREA)
Zoology (AREA)
Gastroenterology & Hepatology (AREA)
Engineering & Computer Science (AREA)
Bioinformatics & Cheminformatics (AREA)
Immunology (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)

SI200931317T 2009-11-13 2009-11-13 Liksisenatid kot dodatek metforminu pri zdravljenju sladkorne bolezni tipa 2 SI2324853T1 (sl)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
EP09175876.3A EP2324853B1 (en)	2009-11-13	2009-11-13	Lixisenatide as add-on to metformin in the treatment of diabetes type 2

Publications (1)

Publication Number	Publication Date
SI2324853T1 true SI2324853T1 (sl)	2015-12-31

Family

ID=41728467

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
SI200931317T SI2324853T1 (sl)	2009-11-13	2009-11-13	Liksisenatid kot dodatek metforminu pri zdravljenju sladkorne bolezni tipa 2

Country Status (9)

Country	Link
EP (1)	EP2324853B1 (sl)
CY (1)	CY1117603T1 (sl)
DK (1)	DK2324853T3 (sl)
ES (1)	ES2553593T3 (sl)
HR (1)	HRP20151230T1 (sl)
HU (1)	HUE026489T2 (sl)
PL (1)	PL2324853T3 (sl)
PT (1)	PT2324853E (sl)
SI (1)	SI2324853T1 (sl)

Families Citing this family (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
HUE048608T2 (hu)	2008-10-17	2020-08-28	Sanofi Aventis Deutschland	Egy inzulin és egy GLP-1 agonista kombinációja
RU2537239C2 (ru)	2009-11-13	2014-12-27	Санофи-Авентис Дойчланд Гмбх	Фармацевтическая композиция, включающая агонист glp-1, инсулин и метионин
LT2498801T (lt)	2009-11-13	2018-05-10	Sanofi-Aventis Deutschland Gmbh	Farmacinė kompozicija, apimanti despro36eksendin-4(1-39)-lys6-nh2 ir metioniną
HUE031181T2 (en)	2010-08-30	2017-06-28	Sanofi Aventis Deutschland	Use of AVE0010 for the manufacture of a medicament for the treatment of type 2 diabetes
JP6381914B2 (ja) *	2011-02-02	2018-08-29	サノフィ−アベンティス・ドイチュラント・ゲゼルシャフト・ミット・ベシュレンクテル・ハフツング	２型糖尿病患者における低血糖の予防
BR112013029062A2 (pt) *	2011-05-13	2016-11-29	Sanofi Aventis Deutschland	lixisenatida e metformina para o tratamento de diabetes tipo 2
US8735349B2 (en) *	2011-05-13	2014-05-27	Sanofi-Aventis Deutschland Gmbh	Method for improving glucose tolerance in a diabetes type 2 patient of younger than 50 years and having postprandial plasma glucose concentration of at least 14 mmol/L
US9821032B2 (en)	2011-05-13	2017-11-21	Sanofi-Aventis Deutschland Gmbh	Pharmaceutical combination for improving glycemic control as add-on therapy to basal insulin
US20130040878A1 (en) *	2011-05-13	2013-02-14	Sanofi-Aventis Deutschland Gmbh	Pharmaceutical combination for use in the treatment of diabetes type 2 patients
RU2650616C2 (ru)	2011-08-29	2018-04-16	Санофи-Авентис Дойчланд Гмбх	Фармацевтическая комбинация для применения при гликемическом контроле у пациентов с сахарным диабетом 2 типа
AR087744A1 (es)	2011-09-01	2014-04-16	Sanofi Aventis Deutschland	Composicion farmaceutica para uso en el tratamiento de una enfermedad neurodegenerativa
FI3229828T3 (fi)	2014-12-12	2023-05-29	Sanofi Aventis Deutschland	Glargiini-insuliinin/liksisenatidin vakiosuhteinen formulaatio
AR103415A1 (es) *	2015-01-16	2017-05-10	Sanofi Aventis Deutschland	Tratamiento de pacientes pediátricos con diabetes mellitus de tipo 2
TWI748945B (zh)	2015-03-13	2021-12-11	德商賽諾菲阿凡提斯德意志有限公司	第２型糖尿病病患治療
TW201705975A (zh)	2015-03-18	2017-02-16	賽諾菲阿凡提斯德意志有限公司	第２型糖尿病病患之治療
WO2021196949A1 (zh)	2020-04-01	2021-10-07	杭州中美华东制药有限公司	一种glp-1受体激动剂的晶型a及其制备方法
EP4141008A4 (en)	2020-04-01	2024-04-17	Hangzhou Zhongmei Huadong Pharmaceutical Co., Ltd.	PHARMACEUTICALLY ACCEPTABLE ACID SALT OF GLP-1 RECEPTOR AGONIST FREE BASE, AND PREPARATION METHOD THEREFOR

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
EP1076066A1 (en)	1999-07-12	2001-02-14	Zealand Pharmaceuticals A/S	Peptides for lowering blood glucose levels

2009
- 2009-11-13 PT PT91758763T patent/PT2324853E/pt unknown
- 2009-11-13 DK DK09175876.3T patent/DK2324853T3/en active
- 2009-11-13 ES ES09175876.3T patent/ES2553593T3/es active Active
- 2009-11-13 EP EP09175876.3A patent/EP2324853B1/en not_active Revoked
- 2009-11-13 HU HUE09175876A patent/HUE026489T2/en unknown
- 2009-11-13 PL PL09175876T patent/PL2324853T3/pl unknown
- 2009-11-13 SI SI200931317T patent/SI2324853T1/sl unknown
2015
- 2015-11-16 HR HRP20151230TT patent/HRP20151230T1/hr unknown
- 2015-11-24 CY CY20151101054T patent/CY1117603T1/el unknown

Also Published As

Publication number	Publication date
PL2324853T3 (pl)	2016-01-29
HUE026489T2 (en)	2016-06-28
EP2324853A1 (en)	2011-05-25
CY1117603T1 (el)	2017-04-26
DK2324853T3 (en)	2015-11-30
ES2553593T3 (es)	2015-12-10
HRP20151230T1 (hr)	2015-12-18
PT2324853E (pt)	2015-11-30
EP2324853B1 (en)	2015-08-26

Similar Documents

Publication	Publication Date	Title
PL2324853T3 (pl)	2016-01-29	Liksysenatyd jako dodatek do metforminy w leczeniu cukrzycy typu 2
HRP20121029T1 (hr)	2013-01-31	Liksisenatid kao pomoä†na terapija uz inzulin glargin i metformin kod lijeäśenja dijabetesa tip 2
ZA200902374B (en)	2009-12-30	Compositions useful for the treatment of diabetes
ZA201001832B (en)	2011-05-25	Improvements relating to fabric treatment compositions
GB0718532D0 (en)	2007-10-31	Improvements relating to fabric treatment compositions
PL2707015T3 (pl)	2017-04-28	Liksysenatyd jako terapia uzupełniająca do insuliny bazalnej w cukrzycy typu 2
SI2707017T1 (sl)	2016-01-29	Liksisenatid in metformin za zdravljenje sladkorne bolezni tipa 2
PL2143429T4 (pl)	2014-07-31	Zastosowanie cylastatyny do zmniejszania nefrotoksyczności różnych związków
IL223289A0 (en)	2013-02-03	Treatment of type 2 diabetes
ZA201103930B (en)	2012-08-29	Improvements relating to fabric treatment compositions
IL208463A (en)	2015-07-30	2-Trotocyclic-Pirol compounds combined, pharmaceutical preparations containing them and their use in the prevention or treatment of diabetes or obesity
PT2842555T (pt)	2018-07-06	Derivados-alfa de ácidos gordos cis-monoinsaturados para uso como medicamentos no tratamento de diabetes
ZA201001831B (en)	2011-05-25	Improvements relating to fabric treatment compositions
ZA201103931B (en)	2012-08-29	Improvements relating to fabric treatment compositions
ZA201001830B (en)	2011-05-25	Improvements relating to fabric treatment compositions
GB0724739D0 (en)	2008-01-30	Improvements relating to fabric treatment compositions
EP2331099A4 (en)	2012-02-29	PHARMACEUTICAL COMPOSITIONS FOR THE TREATMENT OF DIABETES MELLITUS
PL2315651T3 (pl)	2014-08-29	Zastosowanie mediatorów przy produkcji płyt pilśniowych
IL200192A0 (en)	2010-04-15	Composition useful for the treatment of type 2 diabetes
GB0821594D0 (en)	2008-12-31	Improvements in or relating to the treatment of tissue damage
GB0904709D0 (en)	2009-05-06	Improvements in or relating to the transformation of clothing
EP2384338A4 (en)	2013-01-16	GLP-1 ANALOGS AND THEIR APPLICATIONS
GB0723159D0 (en)	2008-01-02	Crockery to which cultery can be attached
GB0809469D0 (en)	2008-07-02	Improvements relating to body jewelry
GB0910889D0 (en)	2009-08-05	Improvements in or relating to treatment tables